TY - JOUR
T1 - Prise en charge de l’anaphylaxie en médecine d’urgence. Recommandations de la Société française de médecine d’urgence (SFMU) en partenariat avec la Société française d’allergologie (SFA) et le Groupe francophone de réanimation et d’urgences pédiatriques (GFRUP), et le soutien de la Société pédiatrique de pneumologie et d’allergologie (SP2A)
AU - Gloaguen, A.
AU - Cesareo, E.
AU - Vaux, J.
AU - Valdenaire, G.
AU - Ganansia, O.
AU - Renolleau, S.
AU - Pouessel, G.
AU - Beaudouin, E.
AU - Lefort, H.
AU - Meininger, C.
AU - Bilbault, Pascal
AU - Mertes, Paul Michel
AU - Beaudouin, Etienne
AU - Moneret-Vautrinc, Denise Anne
AU - Vaux, Julien
AU - Epaud, Ralph
AU - Cesareo, Éric
AU - Rerbal, Djamila
AU - Gloaguen, Aurélie
AU - Bonniaud, Philippe
AU - Dahan, Benjamin
AU - Ganansia, Olivier
AU - Lefort, Hugues
AU - Segal, Nicolas
AU - Zanker, Caroline
AU - Neukirch, Catherine
AU - Renolleau, Sylvain
AU - Corvol, Harriet
AU - Claret, Pierre Géraud
AU - Desclefs, Jean Philippe
AU - Duchenne, Jonathan
AU - Martinez, Mikaël
AU - Rothmann, Christophe
AU - Valdenaire, Guillaume
AU - Goddet, Nathalie Sybille
AU - Schmidt, Jeannot
AU - Soulat, Louis
AU - Pouessel, Guillaume
AU - Leroy, Sylvie
AU - Mariotte, Delphine
AU - Vitte, Joana
AU - Birnbaum, Joëlle
AU - Guinnepain, Marie Thérèse
AU - Daussac, Elisabeth
AU - les membres de la commission des référentiels de la SFMU, et experts de la SFA, du GFRUP et de la SP2A
N1 - Publisher Copyright:
© 2016, Société française de médecine d'urgence and Lavoisier.
PY - 2016/9/1
Y1 - 2016/9/1
N2 - These formalized expert guidelines were written by the French Society of Emergency Medicine (SFMU), in partnership with the French Allergology Society (SFA) and the French Speaking Group in Pediatric Intensive Care and Emergency (GFRUP), and the support of the French Pediatric Pneumology and Allergology Society (SP2A). Their goal is to educate emergency physicians to early diagnosis of this potentially fatal reaction of severe hypersensitivity, the specific features associated with age, and risk factors identification. Anaphylaxis diagnosis is clinical and used Sampson’s clinical criteria. The authors offer helps sheets for emergency medical services dispatch and triage criteria for emergency department nurses. As underlined by the international guidelines, the main treatment is early administration of intramuscular epinephrine. If an epinephrine auto-injector is available, the emergency medical services dispatch center on-call physician (112-call) should encourage its immediate use. The second line of treatment is based on the eviction of the triggering factor, the appropriate waiting position, oxygen therapy, and depending on the symptoms, fluid therapy, bronchodilator and epinephrine nebulization. The severity of the prognosis and the unpredictability of developments justify the deployment of a mobile intensive care unit. A minimum six-hour hospital observation is indicated. Tryptase kinetics evaluation contributes to a posteriori diagnosis. At emergency department discharge, the patient must have a prescription of an emergency kit (containing two epinephrine auto-injectors and β2-agonists), written instructions and a detailed written hospital report. A specialized consultation with an allergologist is essential after the emergency department discharge.
AB - These formalized expert guidelines were written by the French Society of Emergency Medicine (SFMU), in partnership with the French Allergology Society (SFA) and the French Speaking Group in Pediatric Intensive Care and Emergency (GFRUP), and the support of the French Pediatric Pneumology and Allergology Society (SP2A). Their goal is to educate emergency physicians to early diagnosis of this potentially fatal reaction of severe hypersensitivity, the specific features associated with age, and risk factors identification. Anaphylaxis diagnosis is clinical and used Sampson’s clinical criteria. The authors offer helps sheets for emergency medical services dispatch and triage criteria for emergency department nurses. As underlined by the international guidelines, the main treatment is early administration of intramuscular epinephrine. If an epinephrine auto-injector is available, the emergency medical services dispatch center on-call physician (112-call) should encourage its immediate use. The second line of treatment is based on the eviction of the triggering factor, the appropriate waiting position, oxygen therapy, and depending on the symptoms, fluid therapy, bronchodilator and epinephrine nebulization. The severity of the prognosis and the unpredictability of developments justify the deployment of a mobile intensive care unit. A minimum six-hour hospital observation is indicated. Tryptase kinetics evaluation contributes to a posteriori diagnosis. At emergency department discharge, the patient must have a prescription of an emergency kit (containing two epinephrine auto-injectors and β2-agonists), written instructions and a detailed written hospital report. A specialized consultation with an allergologist is essential after the emergency department discharge.
KW - Allergy
KW - Anaphylaxis
KW - Emergency medicine
KW - Epinephrine
KW - Guidelines
UR - http://www.scopus.com/inward/record.url?scp=84988733938&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84988733938&partnerID=8YFLogxK
U2 - 10.1007/s13341-016-0668-2
DO - 10.1007/s13341-016-0668-2
M3 - Article
AN - SCOPUS:84988733938
SN - 2108-6524
VL - 6
SP - 342
EP - 364
JO - Annales Francaises de Medecine d'Urgence
JF - Annales Francaises de Medecine d'Urgence
IS - 5
ER -